BioAge Labs, Inc.

BioAge Labs develops new therapies for cardiometabolic diseases by leveraging the biology of human aging.

2 documented relationships

Hover or select an entity to isolate its relationships. Link thickness reflects the documented amount.

Detailed register

Klaus KlumppAdvisory roleBioAge Labs, Inc.
Reported^{2Klaus Klumpp PhD - Executive Bio, Work History, and Contactspeople.equilar.com}
Role or object indicated by the source: “Advisor”.
James I. Healy, M.D., Ph.D.Board seatBioAge Labs, Inc.
June 10, 2026Reported^{3BioAge Labs Shareholders Reelect Directors, Ratify Auditortheglobeandmail.com}
Position or object indicated by the source: “Class II director”.

Sources

1.
BioAge Labs | Targeting metabolic aging
Web pagebioagelabs.com
View original ↑ Back to text
2.
Klaus Klumpp PhD - Executive Bio, Work History, and Contacts
Web pagepeople.equilar.com
View original ↑ Back to text
3.
BioAge Labs Shareholders Reelect Directors, Ratify Auditor
Web pagetheglobeandmail.com
View original ↑ Back to text